BleedingNCT06211699
Effect of Clips Versus Omentopexy on Postoperative Bleeding
A study testing Omentopexy with Laparoscopic Sleeve Gastrectomy and Clips with Laparoscopic Sleeve Gastrectomy in people with Bleeding and Postoperative Complications, run by Umraniye Education and Research Hospital at 1 site in Turkey (Türkiye).
Trial summary
In this prospective randomized study, patients were divided into two groups: clips group and omentopexy group. The groups were compared in terms of postoperative decrease in hemoglobin and hematocrit values, preoperative and peroperative blood pressure values, duration of surgery, number of patients requiring… Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Bleeding, Postoperative Complications, Postoperative Nausea and Vomiting
- What is being tested?
- Omentopexy with Laparoscopic Sleeve Gastrectomy and Clips with Laparoscopic Sleeve Gastrectomy
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 148 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jul 2023to 25 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- The Patients who underwent LSG
- Between the ages of 18 and 65,
- A Body Mass Index (BMI) ≥ 40 or BMI ≥ 35 with at least one obesity-related comorbidity
Who cannot join
- Patients who underwent other bariatric surgery procedures,
- Patients who declined to be participate
- uncontrolled hypertension
- preoperative history of gastroesophageal reflux disease (GERD) symptoms
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Umraniye Training and Research Hospital
Istanbul, Umraniye, 34764
About this study
Official title: The Effect of Omentopexy and Clips on the Staple Line During Laparoscopic Sleeve Gastrectomy on Early Postoperative Outcomes: A Randomized Trial
In this prospective randomized study, patients were divided into two groups: clips group and omentopexy group. The groups were compared in terms of postoperative decrease in hemoglobin and hematocrit values, preoperative and peroperative blood pressure values, duration of surgery, number of patients requiring erythrocyte suspension (ES) transfusion, length of hospital stay, hospital readmissions in the first 30-days postoperatively and early postoperative complications.
Read the detailed description
This prospective randomized controlled trial was conducted at the University of Health Science Umraniye Training and Research hospital between July 2023 and November 2023. The Patients who underwent LSG, were between the ages of 18 and 65, with a Body Mass Index (BMI) ≥ 40 or BMI ≥ 35 with at least one obesity-related comorbidity were included in the study. Patients who underwent other bariatric surgery procedures, had uncontrolled hypertension, and had preoperative history of gastroesophageal reflux disease (GERD) symptoms were excluded. Approval for the study was received from the ethics committee of tertiary health institution (21.06.2023/218494864). Before the surgery, each of the participants were received comprehensive information about the study, the techniques to be applied were explained, they would be randomly assigned in one of the two groups and the consent form obtained in this context.
Study Groups In the study, patients were divided into two groups: Patients who underwent consecutive clippping along the staple line of the remnant stomach during LSG (clips group) and patients who underwent continuous through-and-through omentopexy of the omentum to the remnant stomach staple line after resection during LSG (omentopexy group).
Data Collection Age, gender, comorbidities, smoking history, preoperative height-weight-BMI values, preoperative systolic blood pressure (SBP)-diastolic blood pressure (DBP) values, preoperative hemoglobin-hematocrit values, peroperative SBP-DBP-mean blood pressure (MBP), duration of surgery, postoperative 6th hour and time of discharge hemoglobin-hematocrit values, number of patients transfused erythrocyte suspension (ES) or requiring invasive intervention due to bleeding, length of hospital stay, hospital readmissions in the first postoperative month, and early postoperative complications were recorded. Duration of surgery was determined from the first skin incision to the last skin suture.
Preoperative, peroperative and Postoperative Evaluation Preoperative anesthesia, cardiology and pulmonology evaluations were performed for each patient. Hepatobiliary ultrasound and upper gastrointestinal endoscopy evaluation were performed. Each patient was administered low molecular weight heparin (enoxaparin 6000 units 1x1 subcutaneously) 12 hours before surgery and was taken to surgery with antiembolism stockings. Intermittant pneumatic compressor device was used perioperatively. Omentopexy was performed with 3-0 V-loc suture (26 mm, V-20 Tapper) and clippping was performed with endo clips II (10 mm, medium/large). Since ERAS protocol was applied in our clinic, no drain was placed in any patient.
At the 4th postoperative hour, all patients were mobilized, intensive respiratory exercise was performed and clear liquid food was started. Complete blood count and C-reactive protein (CRP) laboratory parameters were checked at postoperative 6th, 24th and 48th hour (discharge). Vital parameters were checked every 6 hours postoperatively. Patients who have an acute decrease in hemoglobin value together with a pulse rate of 100 or more per minute and systolic/diastolic blood pressure values below 90/60 mmHg were considered as bleeding and erythrocyte suspension was transfused. Early on the second postoperative day, the patient who could tolerate oral food and did not require additional intervention was discharged.
The primary outcome of the study was to compare the two methods in terms of early postoperative bleeding. The seconder outcome of the study is to compare the groups in terms of duration of surgery, lengh of hospital stay and hospital readmission in the first 30-days postoperatively.
Randomization Patients were numbered according to the order of enrollment and randomly assigned 1:1 to the clips group or the omentopexy group. Allocations were generated using randomly permuted blocks (available at www.randomization.com). All randomization was done by an individual who wasn't included in the study, and the allocations were preserved in sealed envelopes. A research assistant opened the sealed envelope at the beginning of surgery, disclosing the patient's allocation group to the surgeon. The primary surgeon is naturally not blinded to the patient groups and the other surgeon who records and evaluates the data is blinded to the patient groups. All operations were performed laparoscopically by the same surgeon. Since this was a pilot study, no sample size was calculated.
Comparison of Groups The groups were compared in terms of postoperative decrease in hemoglobin and hematocrit values, preoperative and peroperative blood pressure values, duration of surgery, length of hospital stay, hospital readmissions in the first 30-days postoperatively, early postoperative complications and number of patients requiring ES transfusion.
Statical Analaysis A meticulous statistical evaluation was performed on the collected baseline clinical data to ensure robust and reliable conclusions. For continuous variables, the analysis employed both t-tests and Mann-Whitney U tests, depending on the distribution characteristics of the data. Categorical variables, on the other hand, were rigorously examined using either Fisher's exact test or the chi-square test, based on the appropriateness for the dataset at hand.
This analytical process was facilitated by the use of SPSS software, version 22.0 (IBM Corp., Armonk, NY), which is renowned for its precision and versatility in handling diverse statistical tasks. Care was taken to conduct all tests as two-tailed, providing a comprehensive view of the data. The threshold for statistical significance was set at a p value of less than 0.05, aligning with standard practices in clinical research.
- Being tested
- Omentopexy with Laparoscopic Sleeve Gastrectomy, Clips with Laparoscopic Sleeve Gastrectomy
- Keywords
- Laparoscopic Sleeve Gastrectomy, Bleeding, Staple Line Reinforcement, Postoperative First Month Readmission
- Medical subject headings
- Hemorrhage, Postoperative Complications, Postoperative Nausea and Vomiting
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Omentopexy with Laparoscopic Sleeve GastrectomyProcedure or surgery
Patients with omentum sewed to the remnant gastric staple line during laparoscopic sleeve gastrectomy.
Clips with Laparoscopic Sleeve GastrectomyProcedure or surgery
Patients performed clips to the remnant gastric staple line during laparoscopic sleeve gastrectomy
| Study group | Role | What they receive |
|---|---|---|
| Omentopexy with Laparoscopic Sleeve Gastrectomy | Active comparator | Patients who underwent continuous through-and-through omentopexy of the omentum to the remnant stomach staple line after resection during Laparoscopic Sleeve Gastrectomy (omentopexy group). Receives: Procedure: Omentopexy with Laparoscopic Sleeve Gastrectomy |
| Clips with Laparoscopic Sleeve Gastrectomy | Active comparator | Patients who underwent consecutive clippping along the staple line of the remnant stomach during Laparoscopic Sleeve Gastrectomy (clips group) Receives: Procedure: Clips with Laparoscopic Sleeve Gastrectomy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Postoperative Bleeding
The primary outcome of the study was to compare the two methods in terms of early postoperative bleeding. This comparison will be made with hemoglobin and hematocrit values measured at postoperative 6th hour, 24th hour and at discharge. The groups will be compared according to the decrease in hemoglobin and hematocrit values, whether ES displacement is required, and whether intervention is required.
Measured: up to 3 Months
Secondary outcomes (2)
Postoperative First Month Readmission
The seconder outcome of the study is to compare the groups in terms of hospital readmission in the first 30-days postoperatively. Patients readmitted to the hospital in the first postoperative month will be recorded and reasons for readmission will be categorized and groups will be compared.
Measured: 30-days postoperatively
The duration of surgery (minutes)
The seconder outcome of the study is to compare the groups in terms of duration of surgery (minutes) Surgical time will be calculated based on the time between the first port incision and the last skin suture.
Measured: Intraoperative
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Jan 2024
- Study start1 Jul 2023
- Primary completion25 Nov 2023
- Study completion25 Dec 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for BleedingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Prospective Randomized Controlled Trial
- Masking
- Triple blind
- Who is masked
- Participant, Care provider, Outcomes assessor
- Enrolment
- 148 participants (actual)
Sponsor and investigators
- Lead sponsor
- Umraniye Education and Research Hospital
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Abdullah Sisik, Umraniye Education and Research Hospital
- Investigators
- Muhammed Taha Demirpolat, M.D., Study director, Umraniye Education and Research Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06211699
- Sponsor's protocol ID
- 218494864
- Status last verified
- Jan 2024
- First submitted
- 7 Jan 2024
- Last updated
- 18 Jan 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Omentopexy and Clips on the Staple Line During Laparoscopic Sleeve Gastrectomy on Early Postoperative Outcomes: A Randomized Trial
- ClinicalTrials.gov ID
- NCT06211699
- Acronym / sponsor ID
- 218494864
- Keywords
- Laparoscopic Sleeve Gastrectomy, Bleeding, Staple Line Reinforcement, Postoperative First Month Readmission
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 148 participants (actual)
- Lead sponsor
- Umraniye Education and Research HospitalOther government
- Study start
- 1 Jul 2023 (actual)
- Primary completion
- 25 Nov 2023 (actual)
- Study completion
- 25 Dec 2023 (actual)
- First posted
- 18 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this prospective randomized study, patients were divided into two groups: clips group and omentopexy group. The groups were compared in terms of postoperative decrease in hemoglobin and hematocrit values, preoperative and peroperative blood pressure values, duration of surgery, number of patients requiring erythrocyte suspension (ES) transfusion, length of hospital stay, hospital readmissions in the first 30-days postoperatively and early postoperative complications.
Detailed description
This prospective randomized controlled trial was conducted at the University of Health Science Umraniye Training and Research hospital between July 2023 and November 2023. The Patients who underwent LSG, were between the ages of 18 and 65, with a Body Mass Index (BMI) ≥ 40 or BMI ≥ 35 with at least one obesity-related comorbidity were included in the study. Patients who underwent other bariatric surgery procedures, had uncontrolled hypertension, and had preoperative history of gastroesophageal reflux disease (GERD) symptoms were excluded. Approval for the study was received from the ethics committee of tertiary health institution (21.06.2023/218494864). Before the surgery, each of the participants were received comprehensive information about the study, the techniques to be applied were explained, they would be randomly assigned in one of the two groups and the consent form obtained in this context.
Study Groups In the study, patients were divided into two groups: Patients who underwent consecutive clippping along the staple line of the remnant stomach during LSG (clips group) and patients who underwent continuous through-and-through omentopexy of the omentum to the remnant stomach staple line after resection during LSG (omentopexy group).
Data Collection Age, gender, comorbidities, smoking history, preoperative height-weight-BMI values, preoperative systolic blood pressure (SBP)-diastolic blood pressure (DBP) values, preoperative hemoglobin-hematocrit values, peroperative SBP-DBP-mean blood pressure (MBP), duration of surgery, postoperative 6th hour and time of discharge hemoglobin-hematocrit values, number of patients transfused erythrocyte suspension (ES) or requiring invasive intervention due to bleeding, length of hospital stay, hospital readmissions in the first postoperative month, and early postoperative complications were recorded. Duration of surgery was determined from the first skin incision to the last skin suture.
Preoperative, peroperative and Postoperative Evaluation Preoperative anesthesia, cardiology and pulmonology evaluations were performed for each patient. Hepatobiliary ultrasound and upper gastrointestinal endoscopy evaluation were performed. Each patient was administered low molecular weight heparin (enoxaparin 6000 units 1x1 subcutaneously) 12 hours before surgery and was taken to surgery with antiembolism stockings. Intermittant pneumatic compressor device was used perioperatively. Omentopexy was performed with 3-0 V-loc suture (26 mm, V-20 Tapper) and clippping was performed with endo clips II (10 mm, medium/large). Since ERAS protocol was applied in our clinic, no drain was placed in any patient.
At the 4th postoperative hour, all patients were mobilized, intensive respiratory exercise was performed and clear liquid food was started. Complete blood count and C-reactive protein (CRP) laboratory parameters were checked at postoperative 6th, 24th and 48th hour (discharge). Vital parameters were checked every 6 hours postoperatively. Patients who have an acute decrease in hemoglobin value together with a pulse rate of 100 or more per minute and systolic/diastolic blood pressure values below 90/60 mmHg were considered as bleeding and erythrocyte suspension was transfused. Early on the second postoperative day, the patient who could tolerate oral food and did not require additional intervention was discharged.
The primary outcome of the study was to compare the two methods in terms of early postoperative bleeding. The seconder outcome of the study is to compare the groups in terms of duration of surgery, lengh of hospital stay and hospital readmission in the first 30-days postoperatively.
Randomization Patients were numbered according to the order of enrollment and randomly assigned 1:1 to the clips group or the omentopexy group. Allocations were generated using randomly permuted blocks (available at www.randomization.com). All randomization was done by an individual who wasn't included in the study, and the allocations were preserved in sealed envelopes. A research assistant opened the sealed envelope at the beginning of surgery, disclosing the patient's allocation group to the surgeon. The primary surgeon is naturally not blinded to the patient groups and the other surgeon who records and evaluates the data is blinded to the patient groups. All operations were performed laparoscopically by the same surgeon. Since this was a pilot study, no sample size was calculated.
Comparison of Groups The groups were compared in terms of postoperative decrease in hemoglobin and hematocrit values, preoperative and peroperative blood pressure values, duration of surgery, length of hospital stay, hospital readmissions in the first 30-days postoperatively, early postoperative complications and number of patients requiring ES transfusion.
Statical Analaysis A meticulous statistical evaluation was performed on the collected baseline clinical data to ensure robust and reliable conclusions. For continuous variables, the analysis employed both t-tests and Mann-Whitney U tests, depending on the distribution characteristics of the data. Categorical variables, on the other hand, were rigorously examined using either Fisher's exact test or the chi-square test, based on the appropriateness for the dataset at hand.
This analytical process was facilitated by the use of SPSS software, version 22.0 (IBM Corp., Armonk, NY), which is renowned for its precision and versatility in handling diverse statistical tasks. Care was taken to conduct all tests as two-tailed, providing a comprehensive view of the data. The threshold for statistical significance was set at a p value of less than 0.05, aligning with standard practices in clinical research.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, care provider, outcomes assessor)
- Number of arms
- 2
- Model description
- Prospective Randomized Controlled Trial
| Arm | Type | Receives |
|---|---|---|
| Omentopexy with Laparoscopic Sleeve Gastrectomy | Active comparator | Procedure: Omentopexy with Laparoscopic Sleeve GastrectomyPatients who underwent continuous through-and-through omentopexy of the omentum to the remnant stomach staple line after resection during Laparoscopic Sleeve Gastrectomy (omentopexy group). |
| Clips with Laparoscopic Sleeve Gastrectomy | Active comparator | Procedure: Clips with Laparoscopic Sleeve GastrectomyPatients who underwent consecutive clippping along the staple line of the remnant stomach during Laparoscopic Sleeve Gastrectomy (clips group) |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- The Patients who underwent LSG
- Between the ages of 18 and 65,
- A Body Mass Index (BMI) ≥ 40 or BMI ≥ 35 with at least one obesity-related comorbidity
Key exclusion criteria (4 listed)
- Patients who underwent other bariatric surgery procedures,
- Patients who declined to be participate
- uncontrolled hypertension
- preoperative history of gastroesophageal reflux disease (GERD) symptoms
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Omentopexy with Laparoscopic Sleeve GastrectomyPatients with omentum sewed to the remnant gastric staple line during laparoscopic sleeve gastrectomy. | Procedure or surgery | Omentopexy with Laparoscopic Sleeve Gastrectomy |
| Clips with Laparoscopic Sleeve GastrectomyPatients performed clips to the remnant gastric staple line during laparoscopic sleeve gastrectomy | Procedure or surgery | Clips with Laparoscopic Sleeve Gastrectomy |
Primary outcome
Postoperative Bleeding
Time frame: up to 3 Months
The primary outcome of the study was to compare the two methods in terms of early postoperative bleeding. This comparison will be made with hemoglobin and hematocrit values measured at postoperative 6th hour, 24th hour and at discharge. The groups will be compared according to the decrease in hemoglobin and hematocrit values, whether ES displacement is required, and whether intervention is required.
2 secondary outcomes
Postoperative First Month Readmission
Time frame: 30-days postoperatively
The duration of surgery (minutes)
Time frame: Intraoperative
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jan 2024.
- Individual participant dataSharing planned: No
Related trials for Bleeding
Not yet recruitingObservational study
Development and Validation of a TIPS Prognostic Model
Portal Hypertension Related to Cirrhosis, Ascites
Not yet recruitingObservational study
Integrating Wearable Monitoring and Clinical Data for Stroke Early Warning
Stroke, Ischemic Stroke
Active, not recruitingObservational study
Resumption of Anticoagulation After Major Gastrointestinal Bleeding in Patients With Atrial Fibrillation
Atrial Fibrillation (AF), Major Gastrointestinal Bleeding (MGIB)
RecruitingObservational study
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Heavy Menstrual Bleeding, Bleeding Disorder
Not yet recruiting
Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Hemorrhage, Aneurysmal, Cerebral Vasospasm After Subarachnoid Hemorrhage
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Muhammed Taha Demirpolat, M.D. study director
Umraniye Education and Research Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Omentopexy with Laparoscopic Sleeve Gastrectomy and Clips with Laparoscopic Sleeve Gastrectomy in people with Bleeding and Postoperative Complications, run by Umraniye Education and Research Hospital at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Postoperative Bleeding (time frame: up to 3 Months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2024.